Drug recall · February 13, 2013
Carboplatin Injection recall
Why: Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Carboplatin Injection, 450 mg/45 mL (10 mg/mL), 45 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, NDC 61703-339-50 (Hospira label) and NDC 61703-360-50 (Novaplus label), Hospira, Inc., Lake Forest, IL 60045, Product of Australia.
- Lots / codes
lots Z011711AA (Hospira label) and Z011711AB (Novaplus label), Exp. 08/2013
- Quantity
- 31,326 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- November 8, 2012 · Voluntary: Firm initiated
- Classified
- February 6, 2013
- Reported
- February 13, 2013
- Ended
- October 15, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carboplatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.